The prognostic value of the soluble urokinase-type plasminogen activator receptor (s-uPAR) in plasma of breast cancer patients with and without metastatic disease - Nijziel, MR; Van Oerle, R; Hellenbrand, D (J Thromb Haemost, 2003)
et al.